What is Adarza BioSystems?
Adarza BioSystems is a prominent developer and manufacturer of label-free biosensor assays and instruments. Its technology serves critical applications in life science research, drug development, and in-vitro diagnostics. The platform's unique capability lies in its rapid identification and quantification of biological target analyte species in fluid samples without the need for chemical labels or complex processing. Adarza's solutions offer substantial advantages in speed, ease of use, large-scale screening arrays, and custom assay development, while meeting industry standards for sensitivity, sample volume, and dynamic range. The company's products are designed to address a wide spectrum of quantitative analyte detection needs, including cancer biomarker analysis, drug and vaccine development, and research into allergies, immunology, and infectious diseases.
How much funding has Adarza BioSystems raised?
Adarza BioSystems has raised a total of $53.6M across 6 funding rounds:
Angel/Seed
$250K
Series A
$6M
Series B
$5M
Series C
$17M
Series D
$25M
Debt
$350K
Angel/Seed (2013): $250K, investors not publicly disclosed
Series A (2014): $6M led by BioGenerator, Missouri Technology, St Louis Arch Angels, Cultivation Capital, and Serra Capital
Series B (2016): $5M supported by Cultivation Capital and Lewis & Clark Venture Capital
Series C (2017): $17M featuring Rivervest
Series D (2020): $25M backed by Lightchain Capital and 3x5 Partners
Debt (2020): $350K with participation from PPP
Key Investors in Adarza BioSystems
Cultivation Capital
Cultivation Capital is a venture capital firm focused on investing in transformative early-stage companies across life sciences, software, and agriculture. They provide capital and strategic networks to help startups achieve hyper-growth from Seed through Series B stages.
BioGenerator
BioGenerator is an organization dedicated to creating and growing innovative companies in the life sciences sector, offering both venture capital investments and comprehensive startup support services.
St Louis Arch Angels
The St. Louis Arch Angels is an angel investor network that funds early-stage businesses in the St. Louis region, supporting innovative ventures and fostering local economic growth.
What's next for Adarza BioSystems?
The recent major strategic investment in Adarza BioSystems signals a pivotal growth phase for the company. This capital infusion is expected to accelerate the expansion of its product offerings and market reach, particularly within the drug development and diagnostics sectors. Adarza's focus on label-free biosensor technology positions it to capitalize on the increasing demand for faster, more efficient, and cost-effective biological analysis tools. Future strategic initiatives will likely involve further technological advancements, potential partnerships, and scaling manufacturing capabilities to meet growing market demands. The company's trajectory suggests a strong potential for continued innovation and market leadership in the biosensing arena.
See full Adarza BioSystems company page
